Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2015

Date: September 16, 2015
Pages: 128
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: SF2DFB27D71EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Saudi Arabia's sophisticated healthcare system, large market size and government commitment to sector development will continue to attract investments from international pharmaceutical and healthcare companies. The fierce competition among multinationals and increasing availability of generic drugs are downside risks to our otherwise positive outlook.

Headline Expenditure Projections
  • Pharmaceuticals: SAR28.4bn (USD7.6bn) in 2014 to SAR31.8bn (USD8.5bn) in 2015; +11.9% in both local currency and US dollar terms. Forecast unchanged from Q315.
  • Healthcare: SAR102.6bn (USD27.4bn) in 2014 to SAR118.8bn (USD31.7bn) in 2015; +15.8% in both local currency and US dollar terms. Forecast in line with Q315.
BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019)
OTC Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Industry Risk Reward Indicies
Middle East and Africa Risk/Reward Index
Saudi Arabia Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Non-Communicable Diseases
Healthcare Sector
Healthcare Sector Developments
Healthcare Sector Funding
Private Healthcare Sector
Primary Healthcare Provision
Secondary Healthcare Provision
Health Insurance
Medical Tourism
Healthcare Infrastructure Boom
  Table: Healthcare Resources (Saudi Arabia 2009-2014)
  Table: Healthcare Personnel (Saudi Arabia 2009-2014)
  Table: Healthcare Activity (Saudi Arabia 2009-2014)
Information Technology (IT) In Healthcare
Research & Development
Biotechnology
Clinical Trials
Regulatory Development
Regional Regulatory Developments
Free Trade Agreements
Intellectual Property Regime
IP Deficiencies
Counterfeit & Unregistered Drugs
Pricing Regime
Pricing System Reform
Tendering Procedures
Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
Domestic Industry
Foreign Industry
Pharmaceutical Sector Developments
Pharmaceutical Wholesale
Pharmaceutical Retail
Company Profile
GlaxoSmithKline
Hikma Pharmaceuticals Plc
Jamjoom Pharma
Merck & Co
Novartis
Pfizer
Saudi Arabian Japanese Pharmaceutical (SAJA)
Sanofi
SPIMACO
TABUK Pharmaceutical Manufacturing
Demographic Forecast
Demographic Outlook
  Table: Population Headline Indicators (Saudi Arabia 1990-2025)
  Table: Key Population Ratios (Saudi Arabia 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Saudi Arabia 1990-2025)
  Table: Population By Age Group (Saudi Arabia 1990-2025)
  Table: Population By Age Group % (Saudi Arabia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: